SKA2 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76312
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Predicted:
Bovine (93%). Backed by our 100% Guarantee.
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Antibody was raised against a 15 amino acid synthetic peptide from near the amino terminus of human SKA2. The immunogen is located within the first 50 amino acids of SKA2. Amino Acid Squence: YRLEYEIKTNHPDSA
Reactivity Notes
Immunogen displays the following percentage of sequence identity for non-tested species: Rat (80%).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SKA2 Antibody - BSA Free
Western Blot: SKA2 AntibodyBSA Free [NBP1-76312]
Western Blot: SKA2 Antibody [NBP1-76312] - 3T3 cell lysate with SKA2 antibody at (A) 0.5 and (B) 1 ug/mL.Applications for SKA2 Antibody - BSA Free
Application
Recommended Usage
ELISA
1:100-1:2000
Western Blot
0.5 - 1 ug/ml
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SKA2
Alternate Names
FAM33A, family with sequence similarity 33, member A, FLJ12758, MGC110975, spindle and kinetochore associated complex subunit 2, spindle and kinetochore-associated protein 2, spindle and KT (kinetochore) associated 2
Gene Symbol
SKA2
UniProt
Additional SKA2 Products
Product Documents for SKA2 Antibody - BSA Free
Product Specific Notices for SKA2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...